Aldesleukin Terminated Phase 2 Trials for Metastatic Cutaneous Melanoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01271907Drosophila-generated CTL